Breaking Down the Barriers: Challenges With Development and Implementation of an Industry-Sponsored Antimicrobial Stewardship Data Collection and Analysis Tool

Partnership between clinicians and the pharmaceutical industry with a focus on antimicrobial stewardship research initiatives is a necessary step toward meeting the shared goals of combating inappropriate antimicrobial use, improving patient outcomes, and minimizing resistance development. Achieving...

Full description

Saved in:
Bibliographic Details
Published in:Clinical infectious diseases 2014-10, Vol.59 (suppl_3), p.S179-S184
Main Authors: Hermsen, Elizabeth D., McDaneld, Patrick M., Eiland, Edward H., Destache, Christopher J., Lusardi, Katherine, Estrada, Sandy J., Mercier, Renée-Claude, DePestel, Daryl D., Lamp, Kenneth C., Anderson, Evette, Chung, Thomas J., McKinnon, Peggy S.
Format: Article
Language:English
Subjects:
Anti-Infective Agents - therapeutic use
Antimicrobial agents
Antimicrobials
Application service providers
Collaboration
Data analysis
Data collection
Data Collection - methods
Database Management Systems
Disease prevention
Drug Industry
Drug Utilization
Health care industry
Humans
Industrial sites
Infectious diseases
Pharmaceutical industry
Pharmacies
Risk Assessment
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Partnership between clinicians and the pharmaceutical industry with a focus on antimicrobial stewardship research initiatives is a necessary step toward meeting the shared goals of combating inappropriate antimicrobial use, improving patient outcomes, and minimizing resistance development. Achieving these goals requires outcomes-focused data collection and monitoring tools for antimicrobial stewardship programs (ASP) that consider real-world data about how antimicrobials are used to treat patients. Here we highlight the experiences and challenges associated with the development and implementation of an industry-sponsored electronic antimicrobial stewardship data collection and analysis tool (AS-DCAT). The benefits and risks of the industry-sponsored AS-DCAT from the perspectives of the sponsoring company and participating sites are discussed. Barriers encountered as well as general considerations and recommendations for preventing or overcoming those barriers for future studies and tool development are provided.
ISSN:1058-4838
1537-6591
DOI:10.1093/cid/ciu539